Kimer Med, innovative New Zealand biotech start-up, signs contract with Battelle Memorial Institute to pioneer antiviral drug advances

12 month contract focused on the development of new antiviral drugs Novel candidates to be produced using Kimer Med’s broad-spectrum antiviral platform 95% of viral diseases lack an approved antiviral treatment Download high resolution images here: www.kimermed.co.nz/media NELSON, New…